SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-250742
Filing Date
2023-10-04
Accepted
2023-10-04 16:20:02
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d541066ds3.htm S-3 208604
2 EX-5.1 d541066dex51.htm EX-5.1 6272
3 EX-23.1 d541066dex231.htm EX-23.1 3300
4 EX-23.2 d541066dex232.htm EX-23.2 1571
5 EX-FILING FEES d541066dexfilingfees.htm EX-FILING FEES 36375
6 GRAPHIC g541066dsp001.jpg GRAPHIC 2168
7 GRAPHIC g541066dsp1.jpg GRAPHIC 7092
8 GRAPHIC g541066dsp_2.jpg GRAPHIC 7160
9 GRAPHIC g541066g42h70.jpg GRAPHIC 58908
  Complete submission text file 0001193125-23-250742.txt   361581
Mailing Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Dianthus Therapeutics, Inc. /DE/ (Filer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-274863 | Film No.: 231308190
SIC: 2834 Pharmaceutical Preparations